Reduced-intensity regimens: incidence of nonrelapse mortality, relapse, and disease-free and overall survival. (A) Relapse. The 2-year cumulative incidence of relapse was 42% (95% CI, 39-45) for Haplo relative donor (a) and 37% (95% CI, 30-45) for MUD (b) transplants. (B) Nonrelapse mortality. The 2-year cumulative incidence of nonrelapse mortality was 16% (95% CI, 14-19) for Haplo relative donor (a) and 8% (95% CI, 5-13) for MUD (b) transplants. (C) Overall survival. The 2-year probability of overall survival was 54% (95% CI, 51-57) for Haplo relative donor (a) and 67% (95% CI, 60-74) for MUD (b) transplants. (D) Disease-free survival. The 2-year probability of disease-free survival was 41% (95% CI, 38-45) for Haplo relative donor (a) and 55% (95% CI, 47-62) for MUD (b) transplants.